biostudies-literatureUnknown398(10304)Flaxman ACEPINIAID NIH HHSMedical Research CouncilNational Institute for Health Research (NIHR)Wellcome TrustUK Research and InnovationAcademy of Medical SciencesEngineering and Physical Sciences Research CouncilLancet (London, England)981-990https://www.ebi.ac.uk/biostudies/studies/S-EPMC8409975biostudies-literatureReactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002).PMC8409975HHSN272201400008CSGL023\1089COV19OxfordVaccine01211153/Z/18/ZMC_PC_19055EP/R013756/1AMS-CSF4-TorokMC_UU_00004/04NIHR201409220991/Z/20/ZSzigeti AFolegatti PMSheehan EMinassian AMCooper RRamos Lopez FRudiansyah IPollard AJRollier CBeadon KFord KJFuskova MBlackwell LGodfrey LWilliams SJWoods DTorok EMBeckley RWright DKerr DBellamy DMarinou SScreaton GLambe TLees EAKinch JMcEwan JPolo Peralta Alvarez MWalker LTurnbull IMabbett RFinn AHowe EFelle SRitchie ASmith DJPlatt ADavies SKwok JRamasamy MNNoristani RSanders HDouglas ADBibi SSanders KElias SCUlaszewska MDavies JDavies HHawkins SMarchevsky NGFaust SNWatson MEKelly SDejnirattisai WKoleva SJones EWilliams CJAPulido-Gomez DDi Maso CTurner CCrocker WEMWhite RTang KMongkolsapaya JThomas MShaw RHart TCDarton TCKhozoee BMarlow EFerreira DMazur OStuart ASVFurze JVoysey MKasanyinga MTrivett RGreen CPollock KMSpencer AJTurner DPJHill AVSBaker MTran NSmith CCVichos IGreenwood NFerreira Da Silva CBaker PDemissie TMokaya JRoberts HThompson ACamara SJoe CCappuccini FBittaye MOwino NBridges-Webb AMujadidi YFMorter RMweu PLinder AFowler JBissett CBrown CHeath PTHorsington BSeddiqi SClutterbuck EASingh NLazarus RHowell NFlaxman AMarshall JLAdlou SDold CHill HEmary KRWLarkworthy CWLi GSutherland RPoulton ILawrie AMSharpe HRFrancis EBoyd AGreen CALibri VKeen JProvstgaard-Morys SThomas TMYao ABates LAley RMuller JEwer KJLong FThomson ECGilbert SCKerridge SByard NBeveridge ALillie PJSnape MDHarrison DSilva-Reyes LSong RMorey EJenkin DBarrett JRAli ADonnellan FRKinch PDuncan CJADinesh TRajan MCollins AMBletchly HMorshead GRobinson HLopez Ramon RToshner MOxford COVID Vaccine Trial groupDrake-Brockman RMakinson RMcGregor ACSmith APlested ESmith HGhulam Farooq MGoodman ALBell JGibertoni Cruz AWhelan CCifuentes Gutierrez LHillson KKhan LBelij-Rammerstorfer SAngus BSaunders JECicconi PGaliza EAboagye JAley PKHou MMAnslow RfalseReactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002).2021-01-01T00:00:00Z2021 Sep2026-04-08T08:48:56.615Z2022-02-11T15:37:03.63ZS-EPMC84099753448085810.1016/S0140-6736(21)01699-8